Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/kodiak-sciences-to-report-fourth-quarter-and-full-year-2023-financial-results-and-host-business-updates-webcast-on-march-28-2024-302098792.html
https://www.prnewswire.com/news-releases/kodiak-sciences-announces-upcoming-presentation-of-first-time-results-of-ksi-501abc-phase-1-study-at-the-angiogenesis-exudation-and-degeneration-2024-virtual-meeting-302047505.html
https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302026679.html
https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-the-6th-annual-evercore-isi-healthconx-conference-301995217.html
https://www.prnewswire.com/news-releases/kodiak-reboots-tarcocimab-tedromer-development-program-following-strong-positive-results-in-phase-3-diabetic-retinopathy-glow-study-and-following-dialogue-with-us-regulatory-authorities-on-a-regulatory-pathway-for-bla-submission-301978149.html
https://www.fiercebiotech.com/biotech/kodiak-resurrects-failed-eye-drug-after-phase-3-data-rejuvenate-approval-prospects
https://www.prnewswire.com/news-releases/kodiak-sciences-announces-first-time-presentation-of-primary-endpoint-data-from-tarcocimab-tedromer-phase-3-glow-study-in-patients-with-diabetic-retinopathy-at-american-academy-of-ophthalmology-annual-meeting-301975180.html
https://www.prnewswire.com/news-releases/kodiak-sciences-announces-upcoming-presentations-at-the-56th-annual-scientific-meeting-of-the-retina-society-301953169.html
https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference-301921470.html
https://www.fiercebiotech.com/biotech/kodiaks-cmo-hands-notice-month-after-phase-3-trials-sink-eye-drug-hopes